20

2026

-

02

Microread at WHX Labs Dubai 2026


 

World Health Expo (WHX 2026), a major event for the global healthcare sector, was held at Dubai World Trade Centre on February 10–13, 2026. As an important platform for exchange across the Middle Eastern and global healthcare industries, the exhibition brought together healthcare institutions, laboratory specialists, channel partners and industry decision makers from around the world to explore innovations in medical technology and the future of the industry.

At this year’s exhibition, years of investment and market development by Microread’s international business team translated into significant gains in brand influence and market reach. Making its first exhibition appearance of the new year on a stage that brought together healthcare professionals from across the globe, the Chinese molecular diagnostics company demonstrated the strength of China’s precision medicine technologies.

Over the years, Microread has continued to advance its international strategy, strengthening its foundations in product regulatory compliance and certification, distribution networks and technical services, while steadily building a reliable global network of partners.

During WHX 2026, distributors and customers from countries and regions across the Middle East, Europe and Africa gathered at the Microread booth for in-depth discussions on market collaboration models, technical applications and product implementation. With every seat at the discussion tables occupied, technical exchanges taking place throughout the booth and a steady flow of partnership inquiries, the event reflected the results of years of sustained effort.

Microread’s performance demonstrated growing trust in its brand and increasing industry recognition in international markets, as well as the accelerating momentum of partnerships built over time. What the company presented to the world went beyond its products to include the professionalism and global outlook of a Chinese enterprise.

At the exhibition, Microread highlighted comprehensive solutions across its two core product lines: forensic testing and clinical diagnostics. By presenting integrated product portfolios and their practical applications, the company demonstrated both its technical capabilities and the value of its solutions.

Forensic Solutions Supporting Justice

  • STR testing reagents and DNA database solutions: accurate, efficient and reliable.
  • High-throughput forensic testing solutions: meeting the needs of national DNA database development and complex casework.
  • End-to-end technical support: a one-stop service from sample to data.

Clinical Diagnostics Advancing Precision Medicine

  • Reproductive health and genetic testing: supporting health from the very beginning of life.
  • Precision oncology treatment guidance: enabling more evidence-based, personalized treatment.
  • International regulatory compliance and certification: products meet regulatory requirements in multiple countries, supporting access to global markets.

With reliable performance, strong cost efficiency and broad application compatibility, Microread’s solutions attracted laboratory managers, technical experts and government representatives. Inquiries continued from the first day of the exhibition through its final moments. The showcase strengthened Microread’s position in existing markets and helped more international professionals gain a deeper understanding of its product portfolio and the advantages of its solutions.

Through WHX, an international platform for industry exchange, Microread further increased its visibility and influence among professionals worldwide. Industry experts and partners from different countries and regions showed strong interest in its solutions, laying a solid foundation for broader international cooperation.

With steady, determined progress, Microread continues to expand its global presence, introducing more countries and regions to the innovation and practical value of China’s molecular diagnostics technologies.

WHX 2026 was more than an industry gathering; it was an important showcase of the progress made in Microread’s global strategy. From product performance and solution capabilities to its partner network and brand influence, Microread is taking its place on the international stage with growing maturity and confidence.

Looking ahead, Microread will continue to focus on innovative technologies and high-quality solutions, working with partners worldwide to advance precision medicine and forensic science and to bring the strengths of China’s molecular diagnostics industry to the global stage.

The world is taking notice of Microread.

Next page